163 related articles for article (PubMed ID: 38225986)
1. Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss.
Avraham SA; Hossein J; Somri F; Hawash N; Hochman O
Anaesth Rep; 2024; 12(1):e12278. PubMed ID: 38225986
[TBL] [Abstract][Full Text] [Related]
2. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.
Gulak MA; Murphy P
Can J Anaesth; 2023 Aug; 70(8):1397-1400. PubMed ID: 37280458
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.
Milder DA; Milder TY; Liang SS; Kam PCA
Anaesthesia; 2024 Jul; 79(7):735-747. PubMed ID: 38740566
[TBL] [Abstract][Full Text] [Related]
4. Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying.
Fujino E; Cobb KW; Schoenherr J; Gouker L; Lund E
Cureus; 2023 Jul; 15(7):e42153. PubMed ID: 37602101
[TBL] [Abstract][Full Text] [Related]
5. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.
Klein SR; Hobai IA
Can J Anaesth; 2023 Aug; 70(8):1394-1396. PubMed ID: 36977934
[TBL] [Abstract][Full Text] [Related]
6. Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Wu F; Smith MR; Mueller AL; Klapman SA; Everett LL; Houle T; Kuo B; Hobai IA
Can J Anaesth; 2024 Mar; ():. PubMed ID: 38485835
[TBL] [Abstract][Full Text] [Related]
7. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide.
Sherwin M; Hamburger J; Katz D; DeMaria S
Can J Anaesth; 2023 Aug; 70(8):1300-1306. PubMed ID: 37466909
[TBL] [Abstract][Full Text] [Related]
8. Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence.
Queiroz VNF; Falsarella PM; Chaves RCF; Takaoka F; Socolowski LR; Garcia RG
Einstein (Sao Paulo); 2023; 21():eRC0628. PubMed ID: 38126547
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound.
Willson CM; Patel L; Middleton P; Desai M
Cureus; 2024 Apr; 16(4):e58042. PubMed ID: 38738030
[TBL] [Abstract][Full Text] [Related]
10. Point-of-Care Ultrasound Aids in the Management of Patient Taking Semaglutide Before Surgery: A Case Report.
Hodgson JA; Rivera-Rodriguez H; Wu P; Udani J; Weiss J
A A Pract; 2024 Mar; 18(3):e01762. PubMed ID: 38498670
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Nauck MA; Quast DR; Wefers J; Meier JJ
Mol Metab; 2021 Apr; 46():101102. PubMed ID: 33068776
[TBL] [Abstract][Full Text] [Related]
12. The effect of pre-operative gastric ultrasound examination on the choice of general anaesthetic induction technique for non-elective paediatric surgery. A prospective cohort study.
Gagey AC; de Queiroz Siqueira M; Monard C; Combet S; Cogniat B; Desgranges FP; Robinson P; Chassard D; Bouvet L
Anaesthesia; 2018 Mar; 73(3):304-312. PubMed ID: 29265174
[TBL] [Abstract][Full Text] [Related]
13. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
Dahl K; Brooks A; Almazedi F; Hoff ST; Boschini C; Baekdal TA
Diabetes Obes Metab; 2021 Jul; 23(7):1594-1603. PubMed ID: 33710717
[TBL] [Abstract][Full Text] [Related]
14. Comment on: Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
Mizubuti GB; da Silva LM; Silveira SQ; Gilron I; Ho AM
Can J Anaesth; 2024 Jun; ():. PubMed ID: 38872002
[No Abstract] [Full Text] [Related]
15. Pre-operative gastric ultrasound in patients at risk of pulmonary aspiration: a prospective observational cohort study.
Baettig SJ; Filipovic MG; Hebeisen M; Meierhans R; Ganter MT
Anaesthesia; 2023 Nov; 78(11):1327-1337. PubMed ID: 37587543
[TBL] [Abstract][Full Text] [Related]
16. Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide.
Gallwitz B; Giorgino F
Front Endocrinol (Lausanne); 2021; 12():645507. PubMed ID: 34267725
[TBL] [Abstract][Full Text] [Related]
17. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy.
Silveira SQ; da Silva LM; de Campos Vieira Abib A; de Moura DTH; de Moura EGH; Santos LB; Ho AM; Nersessian RSF; Lima FLM; Silva MV; Mizubuti GB
J Clin Anesth; 2023 Aug; 87():111091. PubMed ID: 36870274
[TBL] [Abstract][Full Text] [Related]
18. Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how?
Brunton SA; Mosenzon O; Wright EE
Postgrad Med; 2020 Nov; 132(sup2):48-60. PubMed ID: 32815453
[TBL] [Abstract][Full Text] [Related]
19. Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile.
Kalas MA; Dang TQ; Galura G; Alvarado L; Dwivedi AK; Deoker A; McCallum R
J Investig Med; 2023 Jan; 71(1):11-16. PubMed ID: 36198436
[TBL] [Abstract][Full Text] [Related]
20. [Tracheal intubation and the patient with a full stomach].
Moro ET; Módolo NS
Rev Assoc Med Bras (1992); 2009; 55(2):201-6. PubMed ID: 19488659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
